NCT00139633View on ClinicalTrials.gov

Selective Dose Escalation for Esophageal Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 31, 2000

Study Completion Date

June 30, 2005

Conditions
Esophageal Cancer
Interventions
DRUG

carboplatin, 5FU, Taxol and radiation

Trial Locations (1)

97213

The Oregon Clinic, Portland

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

MedImmune LLC

INDUSTRY

lead

The Oregon Clinic

OTHER